valu radioimmunoguid surgeri first second look laparotomi colorect cancer surgeri rig anti-cea monoclon antibodi patient primari excis second look procedur surgeri colorect carcinoma antibodi percent primari tumour percent princip tumor second look procedur addit inform extent primari tumor patient percent excis primari carcinoma patient percent second look seri incorrect inform extent primari tumour patient percent wherea incorrect inform second look procedur rig subsequ duke stage percent first look case sensit percent specif percent accur identif individu node imposs techniqu surgic procedur case percent primari surgeri patient undergo second look laparotomi percent rig primari colorect carcinoma addit inform extent advanc tumor particular principl subsequ surgeri techniqu role second look procedur extent recurr tumour follow-up seri addit inform techniqu 